The Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world.
Reihe
Auflage
Sprache
Verlagsort
Verlagsgruppe
Dateigröße
ISBN-13
978-0-470-71836-0 (9780470718360)
Schweitzer Klassifikation
1 - Tinnitus [Seite 5]
1.1 - Contents [Seite 7]
1.1.1 - (Chairman) Introduction [Seite 11]
1.1.2 - Classification of tinnitus [Seite 14]
1.1.2.1 - Discussion [Seite 19]
1.1.3 - Epidemiology of tinnitus [Seite 26]
1.1.3.1 - Discussion [Seite 36]
1.1.4 - Measurement of tinnitus in humans [Seite 45]
1.1.4.1 - Discussion [Seite 58]
1.1.5 - Physiologically active cochlear micromechanics-one source of tinnitus [Seite 64]
1.1.5.1 - Discussion [Seite 86]
1.1.6 - Acoustic correlates of tonal tinnitus [Seite 92]
1.1.6.1 - Discussion [Seite 111]
1.1.7 - Animal models of tinnitus [Seite 118]
1.1.7.1 - Discussion [Seite 140]
1.1.8 - Electrophysiological simulation of tinnitus [Seite 149]
1.1.8.1 - Discussion [Seite 155]
1.1.9 - Ototoxic drugs and noise [Seite 161]
1.1.9.1 - Discussion [Seite 175]
1.1.10 - Tinnitus in children with hearing loss [Seite 182]
1.1.10.1 - Discussion [Seite 192]
1.1.11 - Personality of the tinnitus patient [Seite 203]
1.1.11.1 - Discussion [Seite 209]
1.1.12 - Tinnitus: surgical treatment [Seite 214]
1.1.12.1 - Discussion [Seite 222]
1.1.13 - Electrical suppression of tinnitus [Seite 227]
1.1.13.1 - Discussion [Seite 235]
1.1.14 - GENERAL DISCUSSION [Seite 242]
1.1.14.1 - Factors that predispose towards or exacerbate tinnitus [Seite 242]
1.1.15 - Tinnitus masking: unresolved problems [Seite 249]
1.1.15.1 - Discussion [Seite 266]
1.1.16 - Drugs in the treatment of tinnitus [Seite 273]
1.1.16.1 - Discussion [Seite 283]
1.1.17 - FINAL GENERAL DISCUSSION [Seite 289]
1.1.17.1 - A central or peripheral source of tinnitus [Seite 289]
1.1.17.2 - Masking and residual inhibition [Seite 296]
1.1.17.3 - Legal aspects of tinnitus [Seite 301]
1.1.18 - Chairman's closing remarks [Seite 305]
1.1.19 - APPENDIX I Definition and classification of tinnitus [Seite 310]
1.1.20 - APPENDIX II Guidelines for recommended procedures in tinnitus testing [Seite 313]
1.1.21 - APPENDIX III Glossary of some relevant acoustical terms [Seite 317]
1.1.22 - Index of contributors [Seite 323]
1.1.23 - Subject index [Seite 325]
